首页 > 最新文献

Clinical Lymphoma Myeloma and Leukemia最新文献

英文 中文
CLL-268 Frequency of MDM2 Promoter Polymorphism del1518 (rs3730485) and its Correlation With Clinic-Haematological Features and Treatment Response in Chronic Lymphocytic Leukemia in Sudanese Patients 苏丹慢性淋巴细胞白血病MDM2启动子多态性del1518 (rs3730485)的频率及其与临床血液学特征和治疗反应的相关性
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01107-2
Fady M.M. Abushaqra, Ebrahem H. Al-Mehraby, Jameel S. Alyahary, S. Elbager, Zainab Shumo, Hanan Mohamed, N. Hameed, Basmat Elkhotam, Mohammed H. Albujja, D. Sayed
{"title":"CLL-268 Frequency of MDM2 Promoter Polymorphism del1518 (rs3730485) and its Correlation With Clinic-Haematological Features and Treatment Response in Chronic Lymphocytic Leukemia in Sudanese Patients","authors":"Fady M.M. Abushaqra, Ebrahem H. Al-Mehraby, Jameel S. Alyahary, S. Elbager, Zainab Shumo, Hanan Mohamed, N. Hameed, Basmat Elkhotam, Mohammed H. Albujja, D. Sayed","doi":"10.1016/s2152-2650(23)01107-2","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01107-2","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90249149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CT-534 Allogenic Stem Cell Transplantation for ADA2 deficiency CT-534同种异体干细胞移植治疗ADA2缺陷
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01521-5
Z. Güven, E. Suyanı
{"title":"CT-534 Allogenic Stem Cell Transplantation for ADA2 deficiency","authors":"Z. Güven, E. Suyanı","doi":"10.1016/s2152-2650(23)01521-5","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01521-5","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"46 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90479072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ABCL-517 Phase III Trial of Subcutaneous Epcoritamab + R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2 皮下依可利他单抗+ R-CHOP与单独R-CHOP治疗新诊断弥漫性大b细胞淋巴瘤(DLBCL)的ABCL-517 III期试验:EPCORE DLBCL-2
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01333-2
L. Sehn, M. Chamuleau, G. Lenz, M. Clausen, C. Haioun, K. Izutsu, A. Davies, Jun Zhu, T. Oki, E. Szafer-Glusman, R. Conlon, Hueiyu Chiou, D. Ipe, B. Elliott, Jun Wu, G. Salles
{"title":"ABCL-517 Phase III Trial of Subcutaneous Epcoritamab + R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2","authors":"L. Sehn, M. Chamuleau, G. Lenz, M. Clausen, C. Haioun, K. Izutsu, A. Davies, Jun Zhu, T. Oki, E. Szafer-Glusman, R. Conlon, Hueiyu Chiou, D. Ipe, B. Elliott, Jun Wu, G. Salles","doi":"10.1016/s2152-2650(23)01333-2","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01333-2","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79205939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AML-053 Assessment of Minimal Residual Disease in Patients With Adult Acute Myeloid Leukemia: Single Egyptian Center Experience AML-053评估成人急性髓性白血病患者的最小残留疾病:单个埃及中心经验
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00985-0
M. Moussa, Emad Abd El Mohsen El Hady, Nour Abdallah, Ibrahim Jamal Mahmoud
{"title":"AML-053 Assessment of Minimal Residual Disease in Patients With Adult Acute Myeloid Leukemia: Single Egyptian Center Experience","authors":"M. Moussa, Emad Abd El Mohsen El Hady, Nour Abdallah, Ibrahim Jamal Mahmoud","doi":"10.1016/s2152-2650(23)00985-0","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00985-0","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"238 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79706500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: CML-536 Apparent Cure for Chronic Myeloid Leukemia (CML): Treatment-Free Remission at Academic Centers in Hungary 海报:CML-536明显治愈慢性髓性白血病(CML):匈牙利学术中心的无治疗缓解
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00560-8
Á. Wiedemann, Mária Dömötör, Á. Bátai, L. Horváth, P. Farkas
{"title":"POSTER: CML-536 Apparent Cure for Chronic Myeloid Leukemia (CML): Treatment-Free Remission at Academic Centers in Hungary","authors":"Á. Wiedemann, Mária Dömötör, Á. Bátai, L. Horváth, P. Farkas","doi":"10.1016/s2152-2650(23)00560-8","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00560-8","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"186 5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79728452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: MPN-193 Incidence of Blast Phase in Myelofibrosis According to Anemia Severity MPN-193根据贫血严重程度的骨髓纤维化的成母期发生率
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00637-7
B. Mora, M. Maffioli, E. Rumi, P. Guglielmelli, M. Caramella, A. Kuykendall, F. Palandri, A. Iurlo, V. De Stefano, J. Kiladjian, E. Elli, N. Polverelli, J. Gotlib, F. Albano, R. Silver, G. Benevolo, D. Ross, T. Devos, O. Borsani, T. Barbui, M. D. Porta, L. Bertù, R. Komrokji, A. Vannucchi, F. Passamonti
{"title":"POSTER: MPN-193 Incidence of Blast Phase in Myelofibrosis According to Anemia Severity","authors":"B. Mora, M. Maffioli, E. Rumi, P. Guglielmelli, M. Caramella, A. Kuykendall, F. Palandri, A. Iurlo, V. De Stefano, J. Kiladjian, E. Elli, N. Polverelli, J. Gotlib, F. Albano, R. Silver, G. Benevolo, D. Ross, T. Devos, O. Borsani, T. Barbui, M. D. Porta, L. Bertù, R. Komrokji, A. Vannucchi, F. Passamonti","doi":"10.1016/s2152-2650(23)00637-7","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00637-7","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"27 2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83540433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: TCL-330 RHOA G17V Potentiates CD28-Induced NFAT Transcriptional Activity by Modulating p300 Activity: A Step Further in the Understanding of Follicular Helper T-Cell Lymphoma 海报:TCL-330 RHOA G17V通过调节p300活性增强cd28诱导的NFAT转录活性:进一步了解滤泡辅助性t细胞淋巴瘤
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00791-7
D. Vallois, Mélanie Juilland, Ioannidou Kalliopi, F. Lemmonier, E. Missiaglia, B. Bisig, M. Thome, L. de Leval
{"title":"POSTER: TCL-330 RHOA G17V Potentiates CD28-Induced NFAT Transcriptional Activity by Modulating p300 Activity: A Step Further in the Understanding of Follicular Helper T-Cell Lymphoma","authors":"D. Vallois, Mélanie Juilland, Ioannidou Kalliopi, F. Lemmonier, E. Missiaglia, B. Bisig, M. Thome, L. de Leval","doi":"10.1016/s2152-2650(23)00791-7","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00791-7","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84628890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AML-406 Additional Risk Factors of Severe Bleeding in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML): Ukrainian Prospective Study in a Real-Life Cohort AML-406新诊断急性髓性白血病(AML)患者严重出血的其他危险因素:乌克兰在现实生活队列中的前瞻性研究
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01055-8
Z. Stupakova, I. Dyagil, Z. Martina, A. Sergeieva, O. Karnabeda, U. Melnyk, O. Novosad, S. Rushkovsky
{"title":"AML-406 Additional Risk Factors of Severe Bleeding in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML): Ukrainian Prospective Study in a Real-Life Cohort","authors":"Z. Stupakova, I. Dyagil, Z. Martina, A. Sergeieva, O. Karnabeda, U. Melnyk, O. Novosad, S. Rushkovsky","doi":"10.1016/s2152-2650(23)01055-8","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01055-8","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"55 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89324201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
POSTER: CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience 海报:CT-127评估同种异体干细胞移植后巨细胞病毒感染/疾病频率和危险因素:单中心经验
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)00914-x
Barış Gezici, Ajda Güneş, N. Soyer, G. Saydam, M. Töbü, F. Şahin, F. Vural
{"title":"POSTER: CT-127 Evaluation of Cytomegalovirus Infection/Disease Frequency and Risk Factors Following Allogeneic Stem Cell Transplantation: A Single Center Experience","authors":"Barış Gezici, Ajda Güneş, N. Soyer, G. Saydam, M. Töbü, F. Şahin, F. Vural","doi":"10.1016/s2152-2650(23)00914-x","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)00914-x","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87328965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AML-516 KOMET-007 Trial in Progress: A Phase I Study of Ziftomenib in Combination With Venetoclax or Venetoclax/Azacitidine, or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination With Ziftomenib, for the Treatment of Patients With Acute Myeloid Leukemia AML-516 KOMET-007试验正在进行中:Ziftomenib联合Venetoclax或Venetoclax/阿扎胞苷,或标准诱导阿糖胞苷/柔红霉素(7+3)化疗联合Ziftomenib治疗急性髓系白血病患者的I期研究
Pub Date : 2023-09-01 DOI: 10.1016/s2152-2650(23)01074-1
A. Zeidan, A. Fathi, G. Issa, H. Erba, J. Ahsan, Daniel Corum, B. Tomkinson, T. Kozlek, M. Leoni, E. Wang
{"title":"AML-516 KOMET-007 Trial in Progress: A Phase I Study of Ziftomenib in Combination With Venetoclax or Venetoclax/Azacitidine, or Standard Induction Cytarabine/Daunorubicin (7+3) Chemotherapy in Combination With Ziftomenib, for the Treatment of Patients With Acute Myeloid Leukemia","authors":"A. Zeidan, A. Fathi, G. Issa, H. Erba, J. Ahsan, Daniel Corum, B. Tomkinson, T. Kozlek, M. Leoni, E. Wang","doi":"10.1016/s2152-2650(23)01074-1","DOIUrl":"https://doi.org/10.1016/s2152-2650(23)01074-1","url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87402301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Lymphoma Myeloma and Leukemia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1